TG Therapeutics, Inc. (TGTX)
53.89
-1.50
(-2.71%)
USD |
NASDAQ |
Sep 11, 16:00
53.87
-0.02
(-0.04%)
After-Hours: 20:00
TG Therapeutics Price : 53.89 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 55.71 | 56.26 | 53.47 | 53.89 | 1.369M |
| Sep 10, 2026 | 54.36 | 55.41 | 54.01 | 55.39 | 1.368M |
| Sep 09, 2026 | 55.55 | 57.14 | 54.24 | 54.65 | 1.410M |
| Sep 08, 2026 | 55.34 | 55.92 | 54.09 | 55.74 | 1.086M |
| Sep 04, 2026 | 56.30 | 56.70 | 55.56 | 55.98 | 992966.0 |
| Sep 03, 2026 | 57.40 | 58.47 | 56.19 | 56.71 | 1.571M |
| Sep 02, 2026 | 56.18 | 57.87 | 54.70 | 56.90 | 2.362M |
| Sep 01, 2026 | 53.00 | 56.27 | 52.11 | 56.09 | 3.198M |
| Aug 31, 2026 | 53.58 | 54.36 | 52.67 | 54.30 | 1.622M |
| Aug 28, 2026 | 55.53 | 55.53 | 53.83 | 53.93 | 1.031M |
| Aug 27, 2026 | 55.00 | 55.97 | 54.15 | 55.72 | 1.223M |
| Aug 26, 2026 | 55.50 | 56.04 | 54.53 | 55.03 | 963307.0 |
| Aug 25, 2026 | 56.66 | 57.90 | 54.68 | 55.42 | 1.992M |
| Aug 24, 2026 | 53.19 | 56.49 | 52.00 | 56.01 | 2.847M |
| Aug 21, 2026 | 51.10 | 56.87 | 49.97 | 54.27 | 5.558M |
| Aug 20, 2026 | 51.65 | 53.18 | 50.52 | 50.56 | 2.436M |
| Aug 19, 2026 | 51.62 | 52.34 | 50.71 | 51.69 | 1.290M |
| Aug 18, 2026 | 49.28 | 50.29 | 48.98 | 50.26 | 1.195M |
| Aug 17, 2026 | 48.74 | 49.80 | 48.50 | 49.28 | 1.063M |
| Aug 14, 2026 | 47.27 | 48.92 | 47.27 | 48.74 | 1.073M |
| Aug 13, 2026 | 49.70 | 49.70 | 47.53 | 47.94 | 2.770M |
| Aug 12, 2026 | 50.00 | 50.54 | 49.34 | 49.50 | 2.018M |
| Aug 11, 2026 | 49.29 | 50.35 | 49.00 | 49.90 | 1.501M |
| Aug 10, 2026 | 49.26 | 50.00 | 48.50 | 49.16 | 1.912M |
| Aug 07, 2026 | 49.96 | 50.19 | 49.11 | 49.76 | 1.768M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Krystal Biotech, Inc. | 347.00 |
| Alnylam Pharmaceuticals, Inc. | 248.68 |
| BioMarin Pharmaceutical, Inc. | 65.68 |
| Cytokinetics, Inc. | 73.77 |
| Exelixis, Inc. | 56.12 |
Price Related Metrics
| PE Ratio | 19.63 |
| PS Ratio | 10.75 |
| PEG Ratio | 0.031 |
| Price to Book Value | 13.66 |
| Price to Free Cash Flow | 494.19 |
| Earnings Yield | 5.10% |
| Market Cap | 8.249B |
| PEGY Ratio | 0.031 |
| Operating PE Ratio | 63.02 |
| Normalized PE Ratio | 19.26 |